Page last updated: 2024-09-04

torcetrapib and gw 590735

torcetrapib has been researched along with gw 590735 in 1 studies

Compound Research Comparison

Studies (torcetrapib)	Trials (torcetrapib)	Recent Studies (post-2010) (torcetrapib)	Studies (gw 590735)	Trials (gw 590735)	Recent Studies (post-2010) (gw 590735)
273	28	83	11	0	5

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barone, FC; Brusq, JM; Grillot, DA; Hansen, MK; Issandou, M; Legos, JJ; McVey, MJ; White, RF	1

Other Studies

1 other study(ies) available for torcetrapib and gw 590735

Article	Year
Selective CETP inhibition and PPARalpha agonism increase HDL cholesterol and reduce LDL cholesterol in human ApoB100/human CETP transgenic mice. Journal of cardiovascular pharmacology and therapeutics, 2010, Volume: 15, Issue:2 Topics: Animals; Anticholesteremic Agents; Apolipoprotein B-100; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Dose-Response Relationship, Drug; Fenofibrate; Humans; Mice; Mice, Transgenic; PPAR alpha; Propionates; Quinolines; Thiazoles	2010

Article

Year

Selective CETP inhibition and PPARalpha agonism increase HDL cholesterol and reduce LDL cholesterol in human ApoB100/human CETP transgenic mice.

Journal of cardiovascular pharmacology and therapeutics, 2010, Volume: 15, Issue:2

Topics: Animals; Anticholesteremic Agents; Apolipoprotein B-100; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Dose-Response Relationship, Drug; Fenofibrate; Humans; Mice; Mice, Transgenic; PPAR alpha; Propionates; Quinolines; Thiazoles

2010